A federal district judge will hold a joint hearing in October on drug makers’ Novartis and United Therapeutics’ (UT) lawsuits challenging the government’s findings in May that the two companies’ 340B contract pharmacy policies are unlawful.
In a short unpublished order on July 15, U.S. District Judge Dabney Friedrich announced her decision to expedite consideration of the companies’ and the government’s cross motions for summary judgement in both cases, and to hear arguments on those motions simultaneously at a later date. It is unclear whether Friedrich plans ultimately to issue just one ruling on the merits in both cases, or one in each lawsuit.
A federal district judge will hold a joint hearing in October on drug makers’ Novartis and United Therapeutics’ (UT) lawsuits challenging the government’s findings in May that the two companies’ 340B contract pharmacy policies are unlawful.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
